表紙
市場調査レポート

フランスの神経疾患市場における機会:疾病発生率・有病率・外科手術数

France, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

発行 Medtech Insight 商品コード 258254
出版日 ページ情報 英文 101 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
フランスの神経疾患市場における機会:疾病発生率・有病率・外科手術数 France, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes
出版日: 2012年12月31日 ページ情報: 英文 101 Pages
概要

当レポートでは、フランスにおける主な神経障害/疾患の発生率・有病率・外科手術数について調査し、それらのベネルクス諸国、ノルディック諸国およびEU諸国との比較を提供しており、概略以下の構成でお届けします。

第1章 神経障害の概要

  • アルツハイマー病
  • 筋萎縮性側索硬化症(ALS)
  • 動静脈奇(AVM)
  • 双極性障害
  • うつ病
  • てんかん
  • ハンチントン病
  • 水頭症
  • 多発性硬化症(MS)
  • パーキンソン病
  • 統合失調症
  • 脳卒中

第2章 神経および精神障害

  • アルツハイマー病・認知症
  • 筋萎縮性側索硬化症(ALS)
  • 双極性障害
  • 脳血管障害(CVD)
  • うつ病
  • てんかん
  • ハンチントン病
  • 水頭症
  • 多発性硬化症(MS)
  • 重症筋無力症(MG)
  • パーキンソン病
  • 統合失調症

第3章 脳神経外科手術

  • 中欧神経系・末梢神経系の主な障害/疾患
  • 脳血管系および主な障害/疾患
目次
Product Code: A772

This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in France; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom (U.K.). Among the disorders covered by this report are Alzheimer's disease and dementia, amyotrophic lateral sclerosis, bipolar disorder, depression, epilepsy, multiple sclerosis, Parkinson's disease, schizophrenia, and stroke. Among the covered surgical procedures are carotid endarterectomy, cerebral aneurysm clipping, deep brain stimulation, and ventricular shunting/ventriculostomy.

Procedure volumes forecasts are for the years 2010-2016, with aggregate figures for the EU countries of France, Germany, Italy, Spain, and the U.K. as well as for France alone. Disease incidence and prevalence figures are for the year 2010.

In addition to proprietary data utilized from Medtech Insight's internal resources, many agencies and organizations have provided information including Alzheimer's Disease International, Association France Parkinson, European Community Concerted Action on the Epidemiology and Prevention of Dementia Group, French Federation of Parkinson Groups (Federation Francaise des Groupements de Parkinsoniens), French Technical Agency of Information on Hospitals (Agence Technique de l'Information sur l'Hospitalisation), Huntington's Disease Association, Motor Neurone Disease Association, Multiple Sclerosis International Federation, Myasthenia Gravis Association, The Schizophrenia Association, and the World Health Organization, among others.

Table of Contents

1. OVERVIEW OF NEUROLOGICAL DISORDERS

  • 1.1. Alzheimer's Disease
  • 1.2. Amyotrophic Lateral Sclerosis
  • 1.3. Arteriovenous Malformation
  • 1.4. Bipolar Disorder
  • 1.5. Depression
  • 1.6. Epilepsy
  • 1.7. Huntington's Disease
  • 1.8. Hydrocephalus
  • 1.9. Multiple Sclerosis
  • 1.10. Parkinson's Disease
  • 1.11. Schizophrenia
  • 1.12. Stroke
  • Exhibit 1-1: France, Neurosurgery, Procedure Volumes Forecast, by Type, 2010-2016
  • Exhibit 1-2: France, Neurological Diseases/Disorders, Incidence and Prevalence

2. NEUROLOGOICAL AND PSYCHIATRIC DISORDERS

  • 2.1. Alzheimer's Disease and Dementia
    • 2.1.1. Etiology
    • 2.1.2. Epidemiology
  • 2.2. Amyotrophic Lateral Sclerosis
    • 2.2.1. Etiology
    • 2.2.2. Epidemiology
  • 2.3. Bipolar Disorder
    • 2.3.1. Etiology
    • 2.3.2. Epidemiology
  • 2.4. Cerebrovascular Disorders
    • 2.4.1. Arteriovenous Malformation
      • 2.4.1.1. Etiology
      • 2.4.1.2. Epidemiology
    • 2.4.2. Stroke
      • 2.4.2.1. Etiology
      • 2.4.2.2. Epidemiology
  • 2.5. Depression
    • 2.5.1. Etiology
    • 2.5.2. Epidemiology
  • 2.6. Epilepsy
    • 2.6.1. Etiology
    • 2.6.2. Epidemiology
  • 2.7. Huntington's Disease
    • 2.7.1. Etiology
    • 2.7.2. Epidemiology
  • 2.8. Hydrocephalus
    • 2.8.1. Etiology
    • 2.8.2. Epidemiology
  • 2.9. Multiple Sclerosis
    • 2.9.1. Etiology
    • 2.9.2. Epidemiology
  • 2.10. Myasthenia Gravis
    • 2.10.1. Etiology
    • 2.10.2. Epidemiology
  • 2.11. Parkinson's Disease
    • 2.11.1. Etiology
    • 2.11.2. Epidemiology
  • 2.12. Schizophrenia
    • 2.12.1. Etiology
    • 2.12.2. Epidemiology
  • Exhibit 2-1: 2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender
  • Exhibit 2-2: 2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender
  • Exhibit 2-3: 2010, France and Europe, Alzheimer's Disease, Comparative Incidence and Prevalence
  • Exhibit 2-4: 2010, France and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence
  • Exhibit 2-5: 2010, France and Europe, Bipolar Disorder, Comparative Incidence and Prevalence
  • Exhibit 2-6: 2010, France and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence
  • Exhibit 2-7: 2010, France and Europe, Stroke, Comparative Incidence and Prevalence
  • Exhibit 2-8: 2010, France and Europe, Depression, Comparative Prevalence
  • Exhibit 2-9: 2010, France and Europe, Epilepsy, Comparative Incidence and Prevalence
  • Exhibit 2-10: 2010, France and Europe, Huntington's Disease, Comparative Incidence and Prevalence
  • Exhibit 2-11: 2010, France and Europe, Hydrocephalus, Comparative Incidence and Prevalence
  • Exhibit 2-12: 2010, France and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence
  • Exhibit 2-13: 2010, France and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence
  • Exhibit 2-14: 2010, France and Europe, Parkinson's Disease, Comparative Incidence and Prevalence
  • Exhibit 2-15: 2010, France and Europe, Schizophrenia, Comparative Incidence and Prevalence

3. NEUROSURGICAL PROCEDURES

  • 3.1. The Brain
    • 3.1.1. The Cerebrum
    • 3.1.2. The Cerebellum
    • 3.1.3. The Brainstem
    • 3.1.4. The Meninges
    • 3.1.5. The Ventricular System
    • 3.1.6. Cerebrospinal Fluid
    • 3.1.7. The Hypothalamus
    • 3.1.8. The Pineal Gland
    • 3.1.9. The Pituitary Gland
  • 3.2. Selected Diseases/Disorders of the Central Nervous System and the Peripheral Nervous System
    • 3.2.1. Hydrocephalus
    • 3.2.2. Movement, Seizure, and Tremor Disorders
      • 3.2.2.1. Alzheimer's Disease
      • 3.2.2.2. Epilepsy
      • 3.2.2.3. Multiple Sclerosis
      • 3.2.2.4. Parkinson's Disease
      • 3.2.2.5. Deep Brain Stimulation
      • 3.2.2.6. Stereotactic Radiosurgery
    • 3.2.3. Traumatic Brain Injury
  • 3.3. The Cerebrovascular System and Selected Diseases/Disorders
    • 3.3.1. The Arterial System
    • 3.3.2. The Venous System
    • 3.3.3. Aneurysm
    • 3.3.4. Arteriovenous Malformation
    • 3.3.5. Stroke
  • Exhibit 3-1: Structural Relationship between the Cerebrum, Cerebellum, and Brainstem
  • Exhibit 3-2: Structure of the Meninges
  • Exhibit 3-3: Ventricles of the Brain
  • Exhibit 3-4: France, Ventricular Shunting and Ventriculostomy, Procedure Volumes Forecast, 2010-2016
  • Exhibit 3-5: France, Deep Brain Stimulation and Stereotactic Radiosurgery, Procedure Volumes Forecast, 2010-2016
  • Exhibit 3-6: France, Evacuation of Subdural Hematoma, Procedure Volumes Forecast, 2010-2016
  • Exhibit 3-7: France, Cerebral Aneurysm Clipping, Procedure Volumes Forecast, 2010-2016
  • Exhibit 3-8: France, Arteriovenous Malformation Embolization, Procedure Volumes Forecast, 2010-2016
  • Exhibit 3-9: France, Carotid Endarterectomy and Carotid Artery Stenting, Procedure Volumes Forecast, 2010-2016
Back to Top